𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The LRRK2 I2012T, G2019S, and I2020T mutations are rare in Taiwanese patients with sporadic Parkinson's disease

✍ Scribed by Chin-Song Lu; Erik J. Simons; Yah-Huei Wu-Chou; Alessio Di Fonzo; Hsiu-Chen Chang; Rou-Shayn Chen; Yi-Hsin Weng; Christan F. Rohé; Guido J. Breedveld; Nobutaka Hattori; Thomas Gasser; Ben A. Oostra; Vincenzo Bonifati

Book ID
116820128
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
63 KB
Volume
11
Category
Article
ISSN
1353-8020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lack of G2019S LRRK2 mutation in a cohor
Lack of G2019S LRRK2 mutation in a cohort of Taiwanese with sporadic Parkinson's disease
✍ Hon-Chung Fung; Chiung-Mei Chen; John Hardy; Dena Hernandez; Andrew Singleton; Y 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB

## Abstract Mutations in the leucine‐rich repeat kinase 2 (__LRRK2__) gene have been shown to cause autosomal dominant and sporadic Parkinson's disease (PD). We report here the frequency of a common heterozygous mutation, 2877510G>A, which produces a glycine‐to‐serine amino acid substitution at cod

Olfactory deficits and cardiac 123I-MIBG
Olfactory deficits and cardiac 123I-MIBG in Parkinson's disease related to the LRRK2 R1441G and G2019S mutations
✍ Javier Ruiz-Martínez; Ana Gorostidi; Estibaliz Goyenechea; Ainhoa Alzualde; Juan 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB

## Abstract It has been proposed that olfactory tests and metaiodobenzylguanidine cardiac scintigraphy may help diagnose idiopathic Parkinson's disease in the premotor phase. However, it is not clear what value these tests have in all patients with Parkinson's disease and, particularly, in those wh